CIK 0001528115 · Non-accelerated filer<br>Smaller reporting company
Annexon, Inc.
Sign in to watch- Ticker
- ANNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 275414423
- Phone
- (650) 822-5500
- Business address
- 1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
- SC 13D Stake Beneficial Ownership Report
- SC 13G Stake Amended Statement of Ownership
- 4 Grant or award EVP & Chief Business Officer acquired 9,375 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award EVP & Chief Scientific Officer acquired 4,688 shares (grant or award)
- 4 Grant or award EVP & Chief Scientific Officer acquired 4,688 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award EVP & Chief Financial Officer acquired 9,375 shares (grant or award)
- 4 Open-market buy Director bought 2,453,988 shares at $3.84 ($9,423,314)
- 8-K Event Material agreement · Unregistered share sale · Other events
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
Page 18 of 27 · 524 filings